I agree that this site is using cookies. You can find further informations here.
X
Loi, Lisa
32  results:
OpenAccess-fulltext X
Search for persons X
?
1

FAP-Specific Signalling Is an Independent Diagnostic Approa..:

Liew, Dawn P ; Röhrich, Manuel ; Loi, Lisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454795/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

Dataset of voxelwise correlated signal values of ADC, rCBV ..:

Röhrich, Manuel ; Loi, Lisa ; Floca, Ralf..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256298/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
3

FAP-Specific Signalling Is an Independent Diagnostic Approa..:

Dawn P. Liew ; Manuel Röhrich ; Lisa Loi...
https://www.mdpi.com/2072-6694/14/17/4253.  , 2022
Link: https://doi.org/10.3390/..
 
?
4

FAP-Specific Signalling Is an Independent Diagnostic Approa..:

Dawn P. Liew ; Manuel Röhrich ; Lisa Loi...
https://dx.doi.org/10.3390/cancers14174253.  , 2022
Link: https://doi.org/10.3390/..
 
?
5

Dataset of voxelwise correlated signal values of ADC, rCBV ..:

Manuel Röhrich ; Lisa Loi ; Ralf Floca..
http://www.sciencedirect.com/science/article/pii/S2352340920306065.  , 2020
Link: https://doi.org/10.1016/..
 
?
6

Immunological and clinicopathological features predict HER2..:

Rediti, Mattia ; Fernandez-Martinez, Aranzazu ; Venet, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624889/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J ; Piha-Paul, Sarina A ; Shah, Ronak H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902444/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF(V60..:

Furfaro, Anna Lisa ; Loi, Giulia ; Ivaldo, Caterina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219655/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

HO‐1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF V60..:

Furfaro, Anna Lisa ; Loi, Giulia ; Ivaldo, Caterina...
Furfaro , A L , Loi , G , Ivaldo , C , Passalacqua , M , Pietra , G , Mann , G E & Nitti , M 2022 , ' HO‐1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF V600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia ' , Antioxidants , vol. 11 , no. 6 , 1171 . https://doi.org/10.3390/antiox11061171.  , 2022
Link: https://kclpure.kcl.ac.u..
 
?
10

Tucatinib vs Placebo, Both in Combination With Trastuzumab ..:

Lin, Nancy U ; Murthy, Rashmi K ; Abramson, Vandana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716438/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

HO‐1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF V60..:

Furfaro, Anna Lisa ; Loi, Giulia ; Ivaldo, Caterina...
Furfaro , A L , Loi , G , Ivaldo , C , Passalacqua , M , Pietra , G , Mann , G E & Nitti , M 2022 , ' HO‐1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF V600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia ' , Antioxidants , vol. 11 , no. 6 , 1171 . https://doi.org/10.3390/antiox11061171.  , 2022
Link: https://kclpure.kcl.ac.u..
 
?
12

Intracranial Efficacy and Survival With Tucatinib Plus Tras..:

Lin, Nancy U ; Borges, Virginia ; Anders, Carey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403000/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Intracranial Efficacy and Survival With Tucatinib Plus Tras..:

Lin, Nancy U ; Borges, Virginia ; Anders, Carey...
qt6zn775k1.  , 2020
Link: https://escholarship.org..
 
?
14

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive ..:

Murthy, Rashmi K ; Loi, Sherene ; Okines, Alicia...
boreal:224403.  , 2020
Link: http://hdl.handle.net/20..
 
?
15

53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITAB..:

Lin, Nancy ; Murthy, Rashmi ; Anders, Carey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401403/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15